Logo image of CXM

SPRINKLR INC-A (CXM) Stock Fundamental Analysis

USA - NYSE:CXM - US85208T1079 - Common Stock

7.875 USD
+0.08 (+1.09%)
Last: 10/27/2025, 11:29:03 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CXM. CXM was compared to 285 industry peers in the Software industry. CXM has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on CXM. These ratings could make CXM a good candidate for value investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CXM had positive earnings in the past year.
CXM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CXM reported negative net income in multiple years.
CXM had a positive operating cash flow in 4 of the past 5 years.
CXM Yearly Net Income VS EBIT VS OCF VS FCFCXM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

CXM has a Return On Assets of 11.07%. This is amongst the best in the industry. CXM outperforms 87.72% of its industry peers.
With an excellent Return On Equity value of 22.11%, CXM belongs to the best of the industry, outperforming 88.07% of the companies in the same industry.
CXM has a Return On Invested Capital of 6.77%. This is in the better half of the industry: CXM outperforms 75.09% of its industry peers.
Industry RankSector Rank
ROA 11.07%
ROE 22.11%
ROIC 6.77%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
CXM Yearly ROA, ROE, ROICCXM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

The Profit Margin of CXM (14.64%) is better than 78.60% of its industry peers.
CXM's Operating Margin of 5.75% is fine compared to the rest of the industry. CXM outperforms 68.77% of its industry peers.
The Gross Margin of CXM (69.94%) is comparable to the rest of the industry.
CXM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.75%
PM (TTM) 14.64%
GM 69.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
CXM Yearly Profit, Operating, Gross MarginsCXM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CXM is destroying value.
Compared to 1 year ago, CXM has less shares outstanding
Compared to 5 years ago, CXM has more shares outstanding
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CXM Yearly Shares OutstandingCXM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXM Yearly Total Debt VS Total AssetsCXM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

CXM has an Altman-Z score of 2.33. This is not the best score and indicates that CXM is in the grey zone with still only limited risk for bankruptcy at the moment.
CXM has a Altman-Z score of 2.33. This is comparable to the rest of the industry: CXM outperforms 51.93% of its industry peers.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.33
ROIC/WACC0.62
WACC11%
CXM Yearly LT Debt VS Equity VS FCFCXM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

CXM has a Current Ratio of 1.55. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
CXM has a Current ratio (1.55) which is in line with its industry peers.
CXM has a Quick Ratio of 1.55. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CXM (1.55) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55
CXM Yearly Current Assets VS Current LiabilitesCXM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.38% over the past year.
The Revenue has been growing slightly by 6.08% in the past year.
The Revenue has been growing by 19.68% on average over the past years. This is quite good.
EPS 1Y (TTM)15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)6.08%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%7.52%

3.2 Future

Based on estimates for the next years, CXM will show a small growth in Earnings Per Share. The EPS will grow by 6.73% on average per year.
Based on estimates for the next years, CXM will show a quite strong growth in Revenue. The Revenue will grow by 8.78% on average per year.
EPS Next Y24.29%
EPS Next 2Y15.34%
EPS Next 3Y16.02%
EPS Next 5Y6.73%
Revenue Next Year5.33%
Revenue Next 2Y5.35%
Revenue Next 3Y6.6%
Revenue Next 5Y8.78%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CXM Yearly Revenue VS EstimatesCXM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CXM Yearly EPS VS EstimatesCXM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.50, the valuation of CXM can be described as rather expensive.
Based on the Price/Earnings ratio, CXM is valued cheaply inside the industry as 81.40% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.89. CXM is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.91, CXM is valued correctly.
Based on the Price/Forward Earnings ratio, CXM is valued cheaply inside the industry as 81.40% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CXM to the average of the S&P500 Index (22.99), we can say CXM is valued slightly cheaper.
Industry RankSector Rank
PE 17.5
Fwd PE 16.91
CXM Price Earnings VS Forward Price EarningsCXM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CXM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CXM is cheaper than 83.86% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXM is valued cheaper than 85.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.48
EV/EBITDA 16.28
CXM Per share dataCXM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CXM's earnings are expected to grow with 16.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y15.34%
EPS Next 3Y16.02%

0

5. Dividend

5.1 Amount

No dividends for CXM!.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (10/27/2025, 11:29:03 AM)

7.875

+0.08 (+1.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-03 2025-09-03/bmo
Earnings (Next)12-02 2025-12-02/amc
Inst Owners85.5%
Inst Owner Change0.55%
Ins Owners5.32%
Ins Owner Change38.71%
Market Cap1.92B
Revenue(TTM)820.77M
Net Income(TTM)120.18M
Analysts68.57
Price Target10.65 (35.24%)
Short Float %11.36%
Short Ratio7.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.1%
Min EPS beat(2)21.24%
Max EPS beat(2)28.97%
EPS beat(4)4
Avg EPS beat(4)28.42%
Min EPS beat(4)21.24%
Max EPS beat(4)39.04%
EPS beat(8)7
Avg EPS beat(8)28.82%
EPS beat(12)11
Avg EPS beat(12)102.99%
EPS beat(16)15
Avg EPS beat(16)86.53%
Revenue beat(2)2
Avg Revenue beat(2)1.51%
Min Revenue beat(2)0.8%
Max Revenue beat(2)2.21%
Revenue beat(4)3
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)2.21%
Revenue beat(8)6
Avg Revenue beat(8)1.06%
Revenue beat(12)9
Avg Revenue beat(12)1.03%
Revenue beat(16)13
Avg Revenue beat(16)1.41%
PT rev (1m)1.9%
PT rev (3m)-0.53%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-1%
EPS NY rev (1m)0.02%
EPS NY rev (3m)7.88%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)1.28%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 17.5
Fwd PE 16.91
P/S 2.34
P/FCF 16.48
P/OCF 14.44
P/B 3.54
P/tB 3.9
EV/EBITDA 16.28
EPS(TTM)0.45
EY5.71%
EPS(NY)0.47
Fwd EY5.91%
FCF(TTM)0.48
FCFY6.07%
OCF(TTM)0.55
OCFY6.92%
SpS3.36
BVpS2.23
TBVpS2.02
PEG (NY)0.72
PEG (5Y)N/A
Graham Number4.75
Profitability
Industry RankSector Rank
ROA 11.07%
ROE 22.11%
ROCE 7.97%
ROIC 6.77%
ROICexc 34.31%
ROICexgc 60.12%
OM 5.75%
PM (TTM) 14.64%
GM 69.94%
FCFM 14.21%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 87.2%
Cap/Sales 2.01%
Interest Coverage 250
Cash Conversion 201.39%
Profit Quality 97.05%
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z 2.33
F-Score6
WACC11%
ROIC/WACC0.62
Cap/Depr(3y)122.21%
Cap/Depr(5y)126.89%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y24.29%
EPS Next 2Y15.34%
EPS Next 3Y16.02%
EPS Next 5Y6.73%
Revenue 1Y (TTM)6.08%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%7.52%
Revenue Next Year5.33%
Revenue Next 2Y5.35%
Revenue Next 3Y6.6%
Revenue Next 5Y8.78%
EBIT growth 1Y14.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.55%
EBIT Next 3Y36.99%
EBIT Next 5Y28.36%
FCF growth 1Y210.28%
FCF growth 3YN/A
FCF growth 5Y33.79%
OCF growth 1Y134.25%
OCF growth 3YN/A
OCF growth 5Y32.54%

SPRINKLR INC-A / CXM FAQ

What is the ChartMill fundamental rating of SPRINKLR INC-A (CXM) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXM.


What is the valuation status of SPRINKLR INC-A (CXM) stock?

ChartMill assigns a valuation rating of 7 / 10 to SPRINKLR INC-A (CXM). This can be considered as Undervalued.


How profitable is SPRINKLR INC-A (CXM) stock?

SPRINKLR INC-A (CXM) has a profitability rating of 5 / 10.


What is the expected EPS growth for SPRINKLR INC-A (CXM) stock?

The Earnings per Share (EPS) of SPRINKLR INC-A (CXM) is expected to grow by 24.29% in the next year.